Skip to main content

Advertisement

Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

Fig. 1

Box-plots and whiskers (25th–75th percentiles) and outliers of measured biomarker concentrations presented by disease group (pre-lumbar puncture diagnosis) and unadjusted pairwise comparisons (p-values). X-axis: pre-lumbar puncture diagnosis. Aβ amyloid beta, AD Alzheimer’s disease, APP amyloid precursor protein, bvFTD behavioural variant frontotemporal dementia, DLB Lewy body dementia, HC healthy controls, NFL neurofilament light chain, PNFA progressive non-fluent aphasia, P-tau phosphorylated tau, SD semantic dementia, T-tau total tau

Back to article page